Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Rocchetti

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Oncotarget|July 15, 2021
A Dynamic Energy Budget (DEB) based modeling framework to describe tumor-in-host growth inhibition and cachexia onset during anticancer treatment in <i>in vivo</i> xenograft studiesElena Maria Tosca, Maurizio Rocchetti, Paolo Magni
Cancer Research|December 11, 2019
A Tumor-in-Host DEB-Based Approach for Modeling Cachexia and Bevacizumab ResistanceElena M Tosca, Maurizio Rocchetti, Enrico Pesenti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 24, 2007
Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systemsPatrizia Crivori, Amedea Morelli, Daniele Pezzetta, et al.
Drug Discovery Today. Technologies|September 21, 2013
Modeling of human tumor xenografts and dose rationale in oncologyMonica Simeoni, Giuseppe De Nicolao, Paolo Magni, et al.
Journal of Economic Entomology|March 20, 2020
Bee Visitation and Fruit Quality in Berries Under Protected Cropping Vary Along the Length of PolytunnelsMark A Hall, Jeremy Jones, Maurizio Rocchetti, et al.
Computer Methods and Programs in Biomedicine|November 28, 2012
A4S: a user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulationMassimiliano Germani, Francesca Del Bene, Maurizio Rocchetti, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2004
The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal womenMaria Gabriella Jannuzzo, Italo Poggesi, Riccardo Spinelli, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2003
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment timeMassimiliano Germani, Paolo Magni, Giuseppe De Nicolao, et al.
IEEE Transactions on Bio-Medical Engineering|January 8, 2009
A minimal model of tumor growth inhibitionPaolo Magni, Massimiliano Germani, Giuseppe De Nicolao, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 12, 2023
Population pharmacokinetic-pharmacodynamic analysis of givinostatFrancesco Fiorentini, Massimiliano Germani, Francesca Del Bene, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Oncotarget|July 15, 2021
A Dynamic Energy Budget (DEB) based modeling framework to describe tumor-in-host growth inhibition and cachexia onset during anticancer treatment in <i>in vivo</i> xenograft studiesElena Maria Tosca, Maurizio Rocchetti, Paolo Magni
Cancer Research|December 11, 2019
A Tumor-in-Host DEB-Based Approach for Modeling Cachexia and Bevacizumab ResistanceElena M Tosca, Maurizio Rocchetti, Enrico Pesenti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 24, 2007
Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systemsPatrizia Crivori, Amedea Morelli, Daniele Pezzetta, et al.
Drug Discovery Today. Technologies|September 21, 2013
Modeling of human tumor xenografts and dose rationale in oncologyMonica Simeoni, Giuseppe De Nicolao, Paolo Magni, et al.
Journal of Economic Entomology|March 20, 2020
Bee Visitation and Fruit Quality in Berries Under Protected Cropping Vary Along the Length of PolytunnelsMark A Hall, Jeremy Jones, Maurizio Rocchetti, et al.
Computer Methods and Programs in Biomedicine|November 28, 2012
A4S: a user-friendly graphical tool for pharmacokinetic and pharmacodynamic (PK/PD) simulationMassimiliano Germani, Francesca Del Bene, Maurizio Rocchetti, et al.
Cancer Chemotherapy and Pharmacology|March 12, 2004
The effects of degree of hepatic or renal impairment on the pharmacokinetics of exemestane in postmenopausal womenMaria Gabriella Jannuzzo, Italo Poggesi, Riccardo Spinelli, et al.
Cancer Chemotherapy and Pharmacology|August 19, 2003
In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment timeMassimiliano Germani, Paolo Magni, Giuseppe De Nicolao, et al.
IEEE Transactions on Bio-Medical Engineering|January 8, 2009
A minimal model of tumor growth inhibitionPaolo Magni, Massimiliano Germani, Giuseppe De Nicolao, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 12, 2023
Population pharmacokinetic-pharmacodynamic analysis of givinostatFrancesco Fiorentini, Massimiliano Germani, Francesca Del Bene, et al.
Pageof 3